Fulgent Genetics (FLGT) Non-Current Deferred Tax Liability (2016 - 2026)

Fulgent Genetics has disclosed Non-Current Deferred Tax Liability across 7 years of filings, most recently posting $6.9 million for Q2 2026.

• In Q2 2026, Non-Current Deferred Tax Liability rose 12.54% year-over-year to $6.9 million; the TTM figure through Jun 2026 stood at $6.9 million (up 12.54% YoY), while the FY2025 annual figure was $6.9 million, up 8.89% from the prior year.
• Non-Current Deferred Tax Liability came in at $6.9 million for Q2 2026 at Fulgent Genetics, down from $7.0 million in the prior quarter.
• In the past five years, Non-Current Deferred Tax Liability ranged from a high of $9.8 million in Q3 2023 to a low of $6.1 million in Q2 2025.
• Average Non-Current Deferred Tax Liability over 4 years is $7.1 million, with a median of $6.9 million recorded in 2024.
• Year-over-year, Non-Current Deferred Tax Liability slumped 31.52% in 2024 and gained 12.54% in 2026.
• Over 4 years, Non-Current Deferred Tax Liability stood at $8.0 million in 2023, then retreated by 19.99% to $6.4 million in 2024, then advanced by 8.89% to $6.9 million in 2025, then retreated by 0.63% to $6.9 million in 2026.
• Per Business Quant data, the three most recent Non-Current Deferred Tax Liability figures were $6.9 million in Q2 2026, $7.0 million in Q1 2026, and $6.9 million in Q4 2025.